John Menditto | Executive Director, IR & Corporate Communications |
David Mazzo | President and CEO |
Joseph Talamo | SVP and CFO |
Keay Nakae | Chardan |
Julian Harrison | HC Wainwright |
Pete Enderlin | MAZ Partners |
Welcome to the Caladrius Biosciences Second Quarter 2018 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions].
As a reminder, this call is being recorded today, August 9, 2018.